# NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe

> **NCT06641661** · — · NOT_YET_RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Gene Polymorphism
- ASCVD

## Interventions

- **DRUG:** Hybutimibe 10mg QD

## Key facts

- **NCT ID:** NCT06641661
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06641661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06641661, "NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06641661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*